InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Hradsky Gregory T., Director. Officer active across 1 companies, notably Cyclacel Pharmaceuticals, Inc.. In total, 2 disclosures have been recorded. The latest transaction was disclosed on 15 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
02,374 shares0
Common Stock
SEC:0001104659-21-082605·
02,374 shares0
Common Stock
SEC:0001104659-21-082605:0·
2 of 2 declarations
About Hradsky Gregory T.
Gregory T. Hradsky is a Director of Cyclacel Pharmaceuticals, Inc. In this role, he participates in the governance of the company, which focuses on developing innovative treatments for cancer. Gregory brings his expertise in corporate strategy and product development, contributing to the direction of key decisions for Cyclacel.
